Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
AVAILABLE
EXPANDED_ACCESS
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
L-Citrulline and Endothelial Function
NCT05722860
Phase 1 Study to Determine the Metabolism and Clearance of Baxdrostat
NCT05961384
Thebaine Urine Testing
NCT07192887
Development of a Mass-spectometry Based Method for Detecting Xenon Application in Humans
NCT02105077
Beta2-adrenergic Agonism and Muscle Remodelling
NCT03565302
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
For full details, please visit the links provided below.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Triheptanoin
Liquid for oral (PO) or enteral tube administration
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ultragenyx Pharmaceutical Inc
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Medical Director
Role: STUDY_DIRECTOR
Ultragenyx Pharmaceutical Inc
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Related Links
Access external resources that provide additional context or updates about the study.
Access to Investigational Therapies / Requesting Access
Dojolvi Patient and Prescribing Information Page
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UX007-EAP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.